ATE501258T1 - Lawsonia intracellularis impfstoff - Google Patents
Lawsonia intracellularis impfstoffInfo
- Publication number
- ATE501258T1 ATE501258T1 AT05104073T AT05104073T ATE501258T1 AT E501258 T1 ATE501258 T1 AT E501258T1 AT 05104073 T AT05104073 T AT 05104073T AT 05104073 T AT05104073 T AT 05104073T AT E501258 T1 ATE501258 T1 AT E501258T1
- Authority
- AT
- Austria
- Prior art keywords
- relates
- lawsonia intracellularis
- nucleic acid
- detection
- dna
- Prior art date
Links
- 241001148567 Lawsonia intracellularis Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 108020004414 DNA Proteins 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00204660 | 2000-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501258T1 true ATE501258T1 (de) | 2011-03-15 |
Family
ID=8172486
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01204919T ATE330013T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
| AT05104073T ATE501258T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01204919T ATE330013T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6921536B2 (de) |
| EP (2) | EP1586646B1 (de) |
| JP (1) | JP4237960B2 (de) |
| AT (2) | ATE330013T1 (de) |
| AU (1) | AU783210B2 (de) |
| CA (1) | CA2365494A1 (de) |
| DE (2) | DE60144201D1 (de) |
| DK (2) | DK1219711T3 (de) |
| ES (2) | ES2266090T3 (de) |
| HU (1) | HUP0105379A3 (de) |
| PL (1) | PL205964B1 (de) |
| PT (1) | PT1219711E (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1219711T3 (da) * | 2000-12-20 | 2006-09-25 | Intervet Int Bv | Lawsonia Intracellularis vaccine |
| CA2499885C (en) | 2002-05-29 | 2010-04-20 | Yamasa Corporation | Novel polyphosphate:amp phosphotransferase |
| US7662390B2 (en) | 2003-09-12 | 2010-02-16 | Intarvet International B.V. | Lawsonia intracellularis subunit vaccine |
| MXPA06008217A (es) * | 2004-01-22 | 2007-05-23 | Intervet Int Bv | Vacunas con subunidad de lawsonia intracellularis. |
| MY146476A (en) | 2004-06-24 | 2012-08-15 | Boehringer Ingelheim Vetmed | Method of diagnosing lawsonia intracellularis |
| EP1609870A1 (de) * | 2004-06-24 | 2005-12-28 | Boehringer Ingelheim Vetmedica Gmbh | Methode, um Lawsonia intracellularis zu diagnostizieren |
| JP2008520231A (ja) * | 2004-11-24 | 2008-06-19 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓの培養方法 |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| WO2006113782A2 (en) * | 2005-04-18 | 2006-10-26 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
| US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
| EP2859900A1 (de) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis |
| WO2009037262A2 (en) | 2007-09-17 | 2009-03-26 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early lawsonia intracellularis infections |
| TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗 |
| ES2534556T3 (es) * | 2008-07-22 | 2015-04-24 | Intervet International Bv | Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos |
| KR101837768B1 (ko) | 2011-05-25 | 2018-03-12 | 건국대학교 산학협력단 | 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용 |
| US20140017268A1 (en) * | 2012-06-05 | 2014-01-16 | Regents Of The University Of Minnesota | Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections |
| EP3253409B1 (de) | 2015-02-04 | 2020-05-06 | Intervet International B.V. | Impfstoff zur verwendung gegen subklinische lawsonia-infektion bei einem schwein |
| US10265392B2 (en) | 2015-02-04 | 2019-04-23 | Intervet Inc. | Vaccine for use against subclinical Lawsonia infection in a pig |
| JP7088835B2 (ja) * | 2015-10-16 | 2022-06-21 | カンザス ステイト ユニバーシティ リサーチ ファウンデーション | ブタサーコウイルス３型免疫原性組成物、その製造方法、およびその使用方法 |
| CL2017002196A1 (es) | 2017-08-30 | 2017-11-17 | Univ De Concepción | Vacuna recombinante contra enteropatía proliferativa en animales. |
| CN113528683A (zh) * | 2021-07-09 | 2021-10-22 | 南京农业大学 | 一种用于检测胞内劳森菌的绝对荧光定量pcr引物对、试剂盒及检测方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310993A (en) | 1980-01-07 | 1982-01-19 | Louvers & Dampers, Inc. | Louver assembly |
| EP0473210B1 (de) | 1990-07-30 | 1994-04-13 | Akzo Nobel N.V. | Rekombinantes Mareks-Krankheitsvirus |
| WO1993004163A1 (en) | 1991-08-23 | 1993-03-04 | Massachusetts Institute Of Technology | Strain of chlamydia |
| US5610059A (en) * | 1992-11-09 | 1997-03-11 | University Of Arizona | Etiological agent for porcine enteritis |
| FR2714074B1 (fr) | 1993-12-20 | 1996-03-01 | Pasteur Institut | Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs. |
| US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| US5714375A (en) * | 1995-06-05 | 1998-02-03 | Nobl Laboratories, Inc. | Ileal symbiont intracellularis propagation in suspended host cells |
| US7022328B1 (en) * | 1995-11-30 | 2006-04-04 | Australian Pork Limited | Therapeutic and diagnostic compositions |
| CA2372105A1 (en) | 1999-05-13 | 2000-11-23 | Pfizer Products Inc. | Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
| JP2003501013A (ja) | 1999-05-13 | 2003-01-14 | ファイザー プロダクツ インコーポレーティッド | ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用 |
| EP1183268A4 (de) * | 1999-05-13 | 2003-01-02 | Australian Pork Ltd | VON LAWSONIA ABSTAMMENDE GENE UND VERWANDTE OmpHPOLYPEPTIDE, PEPTIDE UND PROTEINE UND IHRE VERWENDUNGEN |
| WO2000069904A1 (en) | 1999-05-13 | 2000-11-23 | Pfizer Products Inc | LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| US6605696B1 (en) * | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| EP1094070A3 (de) | 1999-10-22 | 2002-01-09 | Pfizer Products Inc. | Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden |
| DK1219711T3 (da) * | 2000-12-20 | 2006-09-25 | Intervet Int Bv | Lawsonia Intracellularis vaccine |
-
2001
- 2001-12-14 DK DK01204919T patent/DK1219711T3/da active
- 2001-12-14 AT AT01204919T patent/ATE330013T1/de active
- 2001-12-14 PT PT01204919T patent/PT1219711E/pt unknown
- 2001-12-14 EP EP05104073A patent/EP1586646B1/de not_active Expired - Lifetime
- 2001-12-14 ES ES01204919T patent/ES2266090T3/es not_active Expired - Lifetime
- 2001-12-14 DE DE60144201T patent/DE60144201D1/de not_active Expired - Lifetime
- 2001-12-14 EP EP01204919A patent/EP1219711B1/de not_active Expired - Lifetime
- 2001-12-14 AT AT05104073T patent/ATE501258T1/de not_active IP Right Cessation
- 2001-12-14 DK DK05104073.1T patent/DK1586646T3/da active
- 2001-12-14 ES ES05104073T patent/ES2360225T3/es not_active Expired - Lifetime
- 2001-12-14 DE DE60120621T patent/DE60120621T2/de not_active Expired - Lifetime
- 2001-12-18 CA CA002365494A patent/CA2365494A1/en not_active Abandoned
- 2001-12-19 JP JP2001385373A patent/JP4237960B2/ja not_active Expired - Fee Related
- 2001-12-19 PL PL351277A patent/PL205964B1/pl not_active IP Right Cessation
- 2001-12-19 HU HU0105379A patent/HUP0105379A3/hu unknown
- 2001-12-20 US US10/034,500 patent/US6921536B2/en not_active Expired - Fee Related
- 2001-12-20 AU AU97371/01A patent/AU783210B2/en not_active Ceased
-
2005
- 2005-07-13 US US11/180,997 patent/US7491401B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1586646A2 (de) | 2005-10-19 |
| PL205964B1 (pl) | 2010-06-30 |
| JP2003000276A (ja) | 2003-01-07 |
| EP1586646B1 (de) | 2011-03-09 |
| US20050069559A1 (en) | 2005-03-31 |
| AU783210B2 (en) | 2005-10-06 |
| JP4237960B2 (ja) | 2009-03-11 |
| DK1219711T3 (da) | 2006-09-25 |
| ES2266090T3 (es) | 2007-03-01 |
| US20050250150A1 (en) | 2005-11-10 |
| PL351277A1 (en) | 2002-07-01 |
| DE60120621T2 (de) | 2006-12-14 |
| CA2365494A1 (en) | 2002-06-20 |
| US6921536B2 (en) | 2005-07-26 |
| US7491401B2 (en) | 2009-02-17 |
| AU9737101A (en) | 2002-06-27 |
| DK1586646T3 (da) | 2011-06-27 |
| EP1219711A3 (de) | 2002-11-06 |
| PT1219711E (pt) | 2006-10-31 |
| EP1586646A3 (de) | 2007-08-01 |
| DE60120621D1 (de) | 2006-07-27 |
| HUP0105379A2 (hu) | 2003-01-28 |
| EP1219711A2 (de) | 2002-07-03 |
| DE60144201D1 (de) | 2011-04-21 |
| HUP0105379A3 (en) | 2004-07-28 |
| HU0105379D0 (en) | 2002-02-28 |
| ATE330013T1 (de) | 2006-07-15 |
| EP1219711B1 (de) | 2006-06-14 |
| ES2360225T3 (es) | 2011-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE501258T1 (de) | Lawsonia intracellularis impfstoff | |
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| DE69739981D1 (de) | Streptococcus pneumoniae-Antigene und Impfstoffe | |
| DE60139690D1 (de) | Immunisierung gegen chlamydia pneumoniae | |
| ATE406912T1 (de) | Immunisierung gegen chlamydia tracheomatis | |
| DE60131858D1 (de) | Borrelia burgdorferi rekombinante genkonstrukte | |
| ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
| WO2003058248A3 (en) | Diagnostics and vaccines for mycrobacterium paratuberculosis infections | |
| WO2003095480A3 (en) | Brachyspira hyodysenteriae vaccine | |
| ATE417106T1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
| PT1176192E (pt) | Vacina de helicobacter felis | |
| WO2004024769A3 (en) | Ostertagia vaccine | |
| HUP0200832A2 (hu) | Babesia canis oltóanyag | |
| TH62170A (th) | วัคซีนเชื้อก่อโรค Lawsonia intracellularis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |